SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001005477-08-006783
Filing Date
2008-12-10
Accepted
2008-12-10 14:06:51
Documents
1
Group Members
NEUBERGER BERMAN EQUITY FUNDSNEUBERGER BERMAN MANAGEMENT INC.NEUBERGER BERMAN, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NUMBER 5 TO SCHEDULE 13G file001.txt SC 13G/A 17933
  Complete submission text file 0001005477-08-006783.txt   20035
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-12338 | Film No.: 081240671
SIC: 2834 Pharmaceutical Preparations

Mailing Address 605 THIRD AVE NEW YORK NY 10158
Business Address 605 THIRD AVE NEW YORK NY 10158 2124764654
NEUBERGER BERMAN INC (Filed by) CIK: 0001068144 (see all company filings)

IRS No.: 061523639 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice